文献速递烧伤瘢痕与激光

消融性点阵CO2激光治疗增生性烧伤瘢痕12年纵向结局与同期患者趋同

Convergence of longitudinal outcomes after ablative fractional CO2 laser treatment for hypertrophic burn scars: A 12-year comparison relative to peers.
PubMed 文献 · Burns · 2026-08-31

该回顾性队列研究纳入2012至2024年澳大利亚西澳州成人烧伤中心接受消融性点阵CO2激光治疗增生性烧伤瘢痕的837例患者、共4005次激光治疗,并与未接受激光的同期住院及门诊患者和匹配队列比较。激光组基线瘢痕更差,但烧伤后3至6个月多个瘢痕、生活质量和症状结局的95%置信区间与常规护理组重叠或趋同;仅一次激光治疗后POSAS瘙痒(p=0.018)和颜色(p=0.027)评分即显著改善。

要点

  • 激光组基线瘢痕负担更重,但治疗后3至6个月多维度结局与未激光的轻瘢痕患者趋同。
  • 仅一次激光治疗后POSAS瘙痒(p=0.018)和颜色(p=0.027)评分显著改善。
  • 12年间共完成4005次激光治疗,覆盖837例增生性烧伤瘢痕患者。

核心结论

  • 消融性点阵CO2激光治疗可改善增生性烧伤瘢痕患者的瘢痕与生活质量结局,并在多个维度和测量指标上随时间与未接受激光的轻瘢痕患者趋同。

研究设计与样本

  • 回顾性队列研究,纳入2012至2024年西澳州成人烧伤中心接受消融性点阵CO2激光治疗的所有患者,并与时间限定队列(全部住院患者及随机抽取的1000例门诊患者)及密切匹配的同行组比较。

主要发现

  • 研究期间共完成4005次激光治疗,涉及837例患者。
  • 激光治疗组基线瘢痕质量较同行组更差。
  • 烧伤后3至6个月,激光组多种瘢痕、生活质量和症状结局的95%置信区间与常规护理组重叠或趋同。
  • 亚组分析显示仅一次激光治疗后POSAS瘙痒评分(p=0.018)和颜色评分(p=0.027)有显著正向变化。

临床怎么用

  • 对于增生性烧伤瘢痕患者,可考虑使用消融性点阵CO2激光治疗以改善瘙痒、颜色及多维瘢痕结局。
  • 治疗前应向患者说明激光组基线瘢痕更重,但治疗后3至6个月结局可与未激光的轻瘢痕患者趋同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In Western Australia, ablative fractional CO2 laser therapy (AFCO2L) was introduced to treat hypertrophic burn scars (HBS) in 2012. The purpose of this study was to review the outcomes of the burn patient cohort who received AFCO2L over the first 12 years of the service; and to compare outcomes of those treated with peers not treated with laser. METHODS: This retrospective cohort study included all patients who received AFCO2L at the Western Australian State Adult Burn Unit between 2012 and 2024. Multidimensional scar outcomes of laser-treated adult burn patients were described and compared with a timebound cohort including all inpatients and a random selection of 1000 outpatients, and a group of closely matched peers. Scar and quality of life (QoL) outcomes were analysed for patients who completed a survey package including the Patient and Observer Scar Assessment Scale (POSAS), SF-36, and customised itch questions. RESULTS: During the study period, a total of 4005 laser sessions involving 837 individuals were completed. Patients receiving AFCO2L had poorer quality scars at baseline compared to their peers. From three to six months after burn, the 95% confidence intervals for various and multiple scar, QoL and symptom outcomes of the laser-treated patient group overlapped, or converged, with those of the routine care groups. A subset analysis found POSAS scores after only one laser treatment had significant positive changes in itch (p = 0.018) and color (p = 0.027). CONCLUSIONS: This study showed that AFCO2L-treated patient scar and quality of life outcomes were improved, and converged over time across multiple domains and measures, with those from patients with lower scar burden who were not treated with laser.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Ziolkowski N, Wood FM, Rea S, et al. Convergence of longitudinal outcomes after ablative fractional CO2 laser treatment for hypertrophic burn scars: A 12-year comparison relative to peers. Burns. 2026. PMID: 42906409. doi:10.1016/j.burns.2026.108196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。